Tukey's correction *P < 0.05, **P < 0.01; ***P < 0.001. (A and B), ANOVA *P < 0.04; (C-E), ANOVA *P < 0.001. Tukey's correction *P < 0.05, **P < 0.01; ***P < 0.001. Student t test ***P < 0.001, *P < 0.05.
Supporting

SUPPLEMENTAL MATERIALS AND METHODS
Mice. All mice used were on a C57BL/6 background and were matched for nicotinamide nucleotide transhydrogenase (Nnt) mutation status . For all studies, animals were weighed weekly. Fresh food was provided on a weekly basis and food consumption was quantified weekly. 
Histology. Severity of NAFLD was determined according to NASH Clinical
Research Network criteria 4 , Intestinal inflammation was assessed as previously Flow cytometry. Single cell suspensions were generated from hepatic digestion as described above 3 . Subsequently, flow cytometry was used to enumerate immune cell populations as previously described [7] [8] [9] . Briefly cells were treated with Colonization was assessed by quantitation of SFB levels in fecal pellets obtained at six weeks of age on the day of (but prior to) the initiation of HFD challenge.
Body weight and food intake were determined weekly as described above.
Terminal serum collection and tissue harvest were performed. In Figure 6A . These mice and age-matched C57BL/6NTac male progeny (bred in the 12 CCHMC in sterile microisolators and treated with either water or Vancomycin prior to birth) were challenged with HFD as described above.
Fecal and intestinal DNA Extraction and 16SDNA qPCR. DNA extraction was carried out according to a published protocol 11 , with the following modifications.
Cells were lysed with a TissueLyser (Qiagen) set at 30Hz for 5 minutes and DNA was resuspended in 50 μL of nuclease-free (DEPC-treated) water. Following extraction, DNA was quantified by NanoDrop ND-1000 and 50ng of DNA template was then amplified in a Light Cycler 480 II using Sybr Green I Master mix (both from Roche) with primers to assess the presence of Segmented Filamentous Bacteria (SFB For GACGCTGAGGCATGAGAGCAT and SFB Rev GACGGCACGGATTGTTATTCA) 12 . SFB levels were then normalized to the total amount of Eubacterial DNA in the sample using EUB specific primers (EUB For ACTCCTACGGGAGGCAGCAGT and EUB Rev ATTACCGCGGCTGCTGGC) 12 .
In vivo cytokine capture assay. An assay that integrates in vivo cytokine production over the 24 hr period of challenge was used to quantify systemic cytokine levels. Specifically, cytokines were detected using the In Vivo Cytokine
Capture Assay (IVCCA) 7, 13 , employing biotinylated capture antibodies, detection antibodies and recombinant protein murine standards, all from eBioscience, as described before. Briefly, biotinylated capture antibodies were injected via tail vein 3 hours prior to LPS challenge and terminal serum collection was performed 24 hours later.
